Physician profile
Sofia N Syed
NPI 1053577577
$1,450.74
in general payments reported to CMS, 2019-2025
9 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $17.24 · 2021: $448 · 2022: $143 · 2023: $21.56 · 2024: $210 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562 · Entertainment: $21.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.39 |
| Entertainment | $21.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $634.23 | 2019-2025 | Precision7, Total30, Precision 7 |
| Coopervision INC. | $503.52 | 2019-2025 | Clariti Contact Lens, Cvi Contact Lens, Myday Contact Lens |
| Regeneron Healthcare Solutions, INC. | $118.56 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $48.78 | 2021 | |
| Ivantis, INC | $35.90 | 2021 | |
| Sight Sciences, INC. | $34.57 | 2021 | |
| Carl Zeiss Meditec, INC. | $32.87 | 2019-2020 | |
| Optos, INC. | $21.56 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Iridex Corporation | $20.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofia Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.